A comparison of chemo-free strategy with G-CSF plus plerixafor on demand versus intermediate-dose cyclophosphamide and G-CSF as PBSC mobilization in newly diagnosed multiple myeloma patients: An Italian explorative cost Analysis

D. Laszlo, GP P. Marcacci, M. Martino, D. Radice, C. Rabascio, B. Lucchetti, A. Magarò, A. Caime, S. Menna, MT T. Lionetti, F. Bertolini

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'A comparison of chemo-free strategy with G-CSF plus plerixafor on demand versus intermediate-dose cyclophosphamide and G-CSF as PBSC mobilization in newly diagnosed multiple myeloma patients: An Italian explorative cost Analysis'. Together they form a unique fingerprint.

Medicine & Life Sciences